title: Expression of inflammatory and apoptosis factors following coronary stent implantation in coronary heart disease patients.
abstract: We investigated the changes in characteristics of neutrophil CD11b, monocyte CD11b, platelet CD62P, endothelin (ET), and neutrophil CD178 in patients with coronary heart disease (CHD) before and after primary coronary stenting. A total of 41 patients with CHD who underwent coronary stenting and 40 control subjects were enrolled in the study. In CHD patients, peripheral blood samples were taken 24 h before and 30 min, 24 h, and 72 h after successful coronary stenting. All markers were significantly elevated in patients with CHD compared with controls (P<0.05). Time-course studies revealed that the expressions of neutrophil CD11b, monocyte CD11b, platelet CD62P, and ET were lower at 30 min post-operation (PO) compared with that at 24 h before operation (BO) (P<0.05). All levels significantly increased from 30 min PO to 24 h PO (P<0.05) and decreased thereafter until 72 h PO (P>0.05). Time course changes in neutrophil CD11b levels after coronary stenting were significantly higher in patients with unstable angina pectoris than in patients with stable angina pectoris (P<0.05). CD11b levels were related to CD62P in patients with CHD (P<0.05). Neutrophil CD11b and monocyte CD11b levels were significantly increased in patients with CHD who underwent coronary stenting compared with controls (P<0.05). Results show that CD11b levels increased, meanwhile, the levels of CD62P and ET increased in CHD patients after coronary stenting. In addition, neutrophil CD178 levels of apoptosis factor in patients, which is important for regression of inflammation, remained high for a period of time after coronary stenting.
authors.affiliation: Center of Clinical Laboratory, Zhongshan Hospital, Xiamen University, Xiamen, 361004, China.
authors.forename: Li-Li
authors.initials: LL
authors.lastname: Liu
authors.forename: Li-Rong
authors.initials: LR
authors.lastname: Lin
authors.forename: Cheng-Xiang
authors.initials: CX
authors.lastname: Lu
authors.forename: Jian-Guo
authors.initials: JG
authors.lastname: Fu
authors.forename: Peng-Li
authors.initials: PL
authors.lastname: Chao
authors.forename: Hong-Wei
authors.initials: HW
authors.lastname: Jin
authors.forename: Zhong-Ying
authors.initials: ZY
authors.lastname: Zhang
authors.forename: Tian-Ci
authors.initials: TC
authors.lastname: Yang
mesh_terms: D060050:Angina, Stable / Q000097:blood / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D000789:Angina, Unstable / Q000097:blood / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D015703:Antigens, CD / Q000096:biosynthesis / Q000097:blood; D017209:Apoptosis / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D001772:Blood Cell Count; D001792:Blood Platelets / Q000276:immunology / Q000473:pathology; D016022:Case-Control Studies; D002448:Cell Adhesion / Q000276:immunology; D016232:Endothelins / Q000096:biosynthesis / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000096:biosynthesis* / Q000097:blood; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology / Q000473:pathology; D009504:Neutrophils / Q000276:immunology / Q000473:pathology; D015607:Stents / Q000009:adverse effects*
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D016232:Endothelins; D007155:Immunologic Factors